Literature DB >> 11716509

In vivo conversion of a glycan to human compatible type by transformed tobacco cells.

K Fujiyama1, N Q Palacpac, H Sakai, Y Kimura, A Shinmyo, T Yoshida, T Seki.   

Abstract

Horseradish peroxidase isozyme C (HRP; EC 1.11.1.7) was used as a model protein to evaluate the capacity of tobacco cells transformed with human beta 1,4-galactosyltransferase (GT6) to modify and galactosylate a foreign glycoprotein. Cells transformed with the HRP gene are designated as BY2-HRP and GT6-HRP, for wild type BY2 and GT6 transformed cells, respectively. Expression of HRP cells was confirmed by isoelectric focusing, peroxidase activity staining, Western blotting, and enzymatic assays. The presence of HRP galactosylated N-glycans in GT6-HRP cells was analyzed by lectin staining, affinity chromatography, and structural analyses of pyridylamino-labeled RCA(120)-bound sugar chains. The structure of Gal(1)GlcNAc(1)Man(5)GlcNAc(2) was proposed based from the results of exoglycosidase digestions and two-dimensional sugar chain mapping. Unlike the HRP produced in BY2-HRP cells, the HRP from GT6-HRP cells has galactosylated glycoproteins that did not bind to the xylose-specific antiserum, suggesting the absence of the beta 1,2-xylose residue in the sugar chain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716509     DOI: 10.1006/bbrc.2001.6006

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig.

Authors:  Seung Hoon Kang; Hahn Sun Jung; Song Jae Lee; Cheon Ik Park; Sang Min Lim; Heajin Park; Byung Sun Kim; Kwang Heum Na; Gyeong Jin Han; Jae Woo Bae; Hyun Joo Park; Keuk Chan Bang; Byung Tae Park; Hye Seong Hwang; In-Soo Jung; Jae Il Kim; Doo Byung Oh; Dong Il Kim; Hirokazu Yagi; Koichi Kato; Dae Kyong Kim; Ha Hyung Kim
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

2.  Role of ABC transporters in cancer chemotherapy.

Authors:  Yue-Li Sun; Atish Patel; Priyank Kumar; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2012-01-17

3.  Characterization of the single-chain Fv-Fc antibody MBP10 produced in Arabidopsis alg3 mutant seeds.

Authors:  Maurice Henquet; Jochem Eigenhuijsen; Thamara Hesselink; Holger Spiegel; Mariëlle Schreuder; Esther van Duijn; Jan Cordewener; Ann Depicker; Alexander van der Krol; Dirk Bosch
Journal:  Transgenic Res       Date:  2010-12-25       Impact factor: 2.788

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.